Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stents | 5 | 2022 | 657 | 0.580 |
Why?
|
| Drug-Eluting Stents | 6 | 2013 | 51 | 0.550 |
Why?
|
| Intermittent Claudication | 1 | 2015 | 31 | 0.520 |
Why?
|
| Popliteal Artery | 1 | 2015 | 40 | 0.520 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2022 | 90 | 0.510 |
Why?
|
| Aortic Valve Stenosis | 3 | 2022 | 177 | 0.490 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2022 | 164 | 0.460 |
Why?
|
| Cardiac Catheterization | 4 | 2022 | 419 | 0.450 |
Why?
|
| Coronary Restenosis | 2 | 2012 | 42 | 0.450 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2014 | 137 | 0.400 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 366 | 0.390 |
Why?
|
| Myocardial Infarction | 5 | 2013 | 807 | 0.370 |
Why?
|
| Heart Valve Diseases | 2 | 2022 | 123 | 0.330 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 2013 | 178 | 0.320 |
Why?
|
| Heart Valve Prosthesis | 3 | 2019 | 222 | 0.310 |
Why?
|
| Femoral Artery | 2 | 2015 | 139 | 0.250 |
Why?
|
| Registries | 4 | 2019 | 733 | 0.230 |
Why?
|
| Coronary Angiography | 2 | 2021 | 866 | 0.210 |
Why?
|
| Coronary Artery Disease | 3 | 2013 | 696 | 0.210 |
Why?
|
| Aneurysm, False | 1 | 2022 | 60 | 0.200 |
Why?
|
| Aortic Valve | 2 | 2022 | 249 | 0.180 |
Why?
|
| Polymers | 4 | 2018 | 244 | 0.180 |
Why?
|
| Tissue Scaffolds | 2 | 2018 | 111 | 0.180 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2021 | 137 | 0.180 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2020 | 102 | 0.170 |
Why?
|
| Preoperative Care | 1 | 2021 | 275 | 0.170 |
Why?
|
| Coronary Vessels | 1 | 2022 | 313 | 0.170 |
Why?
|
| Aged | 11 | 2022 | 14862 | 0.170 |
Why?
|
| Tissue Engineering | 2 | 2018 | 212 | 0.170 |
Why?
|
| Mitral Valve Stenosis | 1 | 2019 | 15 | 0.170 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2018 | 12 | 0.160 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2019 | 99 | 0.160 |
Why?
|
| Urinary Bladder | 1 | 2018 | 108 | 0.150 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2018 | 47 | 0.150 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 323 | 0.150 |
Why?
|
| Angiography | 2 | 2015 | 194 | 0.150 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2017 | 6 | 0.150 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 232 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 424 | 0.140 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 130 | 0.140 |
Why?
|
| Bioprosthesis | 1 | 2017 | 101 | 0.140 |
Why?
|
| Mitral Valve | 1 | 2017 | 166 | 0.140 |
Why?
|
| Biocompatible Materials | 2 | 2018 | 247 | 0.140 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 3259 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2019 | 307 | 0.130 |
Why?
|
| Calcinosis | 1 | 2017 | 241 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2015 | 25 | 0.130 |
Why?
|
| Tibial Arteries | 1 | 2015 | 6 | 0.130 |
Why?
|
| Atherectomy | 1 | 2015 | 7 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 4848 | 0.130 |
Why?
|
| Blood Platelets | 2 | 2014 | 284 | 0.120 |
Why?
|
| Angioplasty, Balloon | 1 | 2015 | 110 | 0.120 |
Why?
|
| Female | 13 | 2022 | 38074 | 0.120 |
Why?
|
| Humans | 18 | 2022 | 68618 | 0.120 |
Why?
|
| Thrombosis | 2 | 2013 | 218 | 0.120 |
Why?
|
| Polyurethanes | 1 | 2014 | 21 | 0.120 |
Why?
|
| Peripheral Arterial Disease | 1 | 2015 | 83 | 0.120 |
Why?
|
| Kidney | 1 | 2019 | 945 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2014 | 631 | 0.110 |
Why?
|
| Male | 12 | 2021 | 37321 | 0.110 |
Why?
|
| Prosthesis Design | 3 | 2019 | 301 | 0.110 |
Why?
|
| Immunosuppressive Agents | 2 | 2013 | 514 | 0.110 |
Why?
|
| Absorbable Implants | 1 | 2012 | 29 | 0.110 |
Why?
|
| Myocardial Revascularization | 1 | 2012 | 56 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2012 | 73 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 166 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2012 | 304 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2019 | 7029 | 0.100 |
Why?
|
| Forecasting | 1 | 2012 | 277 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2013 | 601 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 249 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 504 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2012 | 358 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2012 | 158 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 373 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2021 | 7277 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2013 | 931 | 0.080 |
Why?
|
| Time Factors | 4 | 2019 | 4655 | 0.080 |
Why?
|
| Paclitaxel | 3 | 2013 | 140 | 0.080 |
Why?
|
| Sirolimus | 3 | 2013 | 118 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1085 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2021 | 2007 | 0.060 |
Why?
|
| Everolimus | 2 | 2013 | 26 | 0.050 |
Why?
|
| Risk Factors | 3 | 2019 | 5731 | 0.050 |
Why?
|
| Sternotomy | 1 | 2022 | 18 | 0.050 |
Why?
|
| Metals | 2 | 2013 | 100 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2022 | 62 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2022 | 218 | 0.050 |
Why?
|
| Middle Aged | 5 | 2020 | 21147 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 3705 | 0.050 |
Why?
|
| Echocardiography | 1 | 2022 | 515 | 0.040 |
Why?
|
| Balloon Valvuloplasty | 1 | 2017 | 3 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2019 | 174 | 0.040 |
Why?
|
| France | 1 | 2017 | 26 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 144 | 0.040 |
Why?
|
| North America | 1 | 2017 | 112 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1465 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 901 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 57 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2077 | 0.030 |
Why?
|
| Polyethylene Terephthalates | 1 | 2014 | 29 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2017 | 705 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2014 | 66 | 0.030 |
Why?
|
| Finite Element Analysis | 1 | 2014 | 55 | 0.030 |
Why?
|
| Elasticity | 1 | 2014 | 103 | 0.030 |
Why?
|
| Anisotropy | 1 | 2014 | 105 | 0.030 |
Why?
|
| Polyesters | 1 | 2014 | 55 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 506 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 50 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 208 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 2083 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2673 | 0.030 |
Why?
|
| United States | 2 | 2018 | 7367 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 263 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 652 | 0.030 |
Why?
|
| Platelet Count | 1 | 2012 | 100 | 0.030 |
Why?
|
| Tubulin Modulators | 1 | 2012 | 10 | 0.030 |
Why?
|
| Time | 1 | 2012 | 57 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2324 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1851 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2012 | 215 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2012 | 307 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 1056 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1140 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 2093 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 21403 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 20881 | 0.010 |
Why?
|